Cataract Surgery Experience
Conditions
Brief summary
The goal of this clinical trial is to learn if transcranial magnetic stimulation (TMS) can improve the visual outcomes in patients after cataract surgery. The main question it aims to answer is: • Does TMS improve the visual outcome in patients after cataract surgery? Researchers will compare TMS to the sham-controlled treatment (exposure to recorded sounds of pulses without real magnetic stimulation) to see if TMS works to improve the visual outcomes of patients after cataract surgery. Participants will * Undergo TMS treatment or a sham-controlled treatment for consecutive 5 days. * Visit the clinic once every 2 weeks for checkups and tests.
Interventions
PROCEDURETMS
TMS treatment in this study indicates a non-invasive procedure called transcranial magnetic simulation (TMS) on visual cortex. The treatment intensity is set as 80% of the threshold of each participant. The treatment will be conducted every day for consecutive 5 days.
PROCEDUREcontrol group
The control treatment is a sham-controlled procedure, in which participants will be exposed to the recorded sounds of TMS pulses but without real magnetic stimulation.
Sponsors
Shanghai High Myopia Study Group
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Post cataract surgery * Best-corrected visual acuity less than 0.1logMAR
Exclusion criteria
* Diagnosed with cognitive impairment or mental disorders and unable to cooperate with treatment; * Diagnosed with significant opacity of refractive media that affects observation of visual function; * History of epileptic seizures; * Long term use of psychotropic drugs； * Metal implants in the body.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual acuity | From enrollment to the end of treatment at 2 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Visual field | From enrollment to the end of treatment at 2 weeks |
Other
| Measure | Time frame | Description |
|---|---|---|
| Visual quality | From enrollment to the end of treatment at 12 weeks | Include objective visual quality (contrast sensitivity) and subjective visual quality (visual function questionnaire score). |
Countries
China
Contacts
Primary ContactXiangjia Zhu
Outcome results
None listed